{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:55:10Z","timestamp":1794416110155,"version":"4.9.1"},"reference-count":174,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["13148"],"award-info":[{"award-number":["13148"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["14736"],"award-info":[{"award-number":["14736"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.xcrm.2024.101609","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T11:17:22Z","timestamp":1718709442000},"page":"101609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["The impact of ATP-binding cassette transporters in the diseased brain: Context matters"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0711-2860","authenticated-orcid":false,"given":"Chrysiida","family":"Baltira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-3770","authenticated-orcid":false,"given":"Eleonora","family":"Aronica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7478-3429","authenticated-orcid":false,"given":"William F.","family":"Elmquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-5781","authenticated-orcid":false,"given":"Oliver","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9648-8973","authenticated-orcid":false,"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7489-4885","authenticated-orcid":false,"given":"Jann N.","family":"Sarkaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5453-5201","authenticated-orcid":false,"given":"Pieter","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2812-991X","authenticated-orcid":false,"given":"Mark C.","family":"de Gooijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1037-6269","authenticated-orcid":false,"given":"Olaf","family":"van Tellingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101609_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.xcrm.2024.101609_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv.\u00a0Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2024.101609_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nsmb.3216","article-title":"Mechanistic diversity in ATP-binding cassette (ABC) transporters","volume":"23","author":"Locher","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.xcrm.2024.101609_bib4","doi-asserted-by":"crossref","first-page":"19781","DOI":"10.1074\/jbc.M310785200","article-title":"Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2","volume":"279","author":"Xu","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101609_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.xcrm.2024.101609_bib6","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101609_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101609_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101609_bib9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101609_bib10","doi-asserted-by":"crossref","first-page":"30880","DOI":"10.1074\/jbc.R114.609248","article-title":"Multidrug resistance protein 1 (MRP1, ABCC1), a \"multitasking\" ATP-binding cassette (ABC) transporter","volume":"289","author":"Cole","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101609_bib11","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/brain\/awn222","article-title":"ABCC1: a gateway for pharmacological compounds to the ischaemic brain","volume":"131","author":"Kilic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2024.101609_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2005.11.011","article-title":"Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier","volume":"138","author":"Soontornmalai","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.xcrm.2024.101609_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1172\/JCI8267","article-title":"Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier","volume":"105","author":"Wijnholds","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101609_bib14","article-title":"ABCC subfamily (version 2019.3) in the IUPHAR\/BPS Guide to Pharmacology Database","volume":"2019","author":"Vore","year":"2019","journal-title":"IUPHAR\/BPS GtoPdb CITE"},{"key":"10.1016\/j.xcrm.2024.101609_bib15","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1158\/1078-0432.CCR-12-3105","article-title":"Abcc4 together with abcb1 and abcg2 form a robust cooperative drug efflux system that restricts the brain entry of camptothecin analogues","volume":"19","author":"Lin","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/jpet.103.049858","article-title":"Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity","volume":"306","author":"Potschka","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.xcrm.2024.101609_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2005.12.005","article-title":"Expression of the multidrug transporter MRP2 in the blood-brain barrier after pilocarpine-induced seizures in rats","volume":"69","author":"Hoffmann","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib18","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101609_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2024.101609_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/cpt.1710","article-title":"Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood-Brain Barrier of Human Brain and Glioblastoma","volume":"107","author":"Bao","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2024.101609_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xcrm.2024.101609_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-10-21","volume":"10","author":"Uchida","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.xcrm.2024.101609_bib23","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic Quantification of Human Blood\u2013Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients","volume":"16","author":"Al-Majdoub","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.xcrm.2024.101609_bib24","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1002\/jps.22487","article-title":"Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys","volume":"100","author":"Ito","year":"2011","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.xcrm.2024.101609_bib25","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/jps.23575","article-title":"Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset","volume":"102","author":"Hoshi","year":"2013","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.xcrm.2024.101609_bib26","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3390\/pharmaceutics15051563","article-title":"Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat","volume":"15","author":"Zhang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xcrm.2024.101609_bib27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.xcrm.2024.101609_bib28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cne.21808","article-title":"Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces","volume":"510","author":"Gazzin","year":"2008","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroscience.2008.06.015","article-title":"Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in\u00a0vivo biotinylation","volume":"155","author":"Roberts","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.xcrm.2024.101609_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/dmd.112.050344","article-title":"Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier","volume":"41","author":"Yasuda","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.xcrm.2024.101609_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1143544","article-title":"Heterogeneity of the blood-brain barrier","volume":"4","author":"Wilhelm","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.xcrm.2024.101609_bib32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fphar.2018.00658","article-title":"Modulation of the ATP-Binding Cassette B1 Transporter by Neuro-Inflammatory Cytokines: Role in the Pathogenesis of Alzheimer's Disease","volume":"9","author":"Alasmari","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101609_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22030365","article-title":"Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance","volume":"22","author":"Grewal","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.xcrm.2024.101609_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","article-title":"Alzheimer\u2019s disease prevention: from risk factors to early intervention","volume":"9","author":"Crous-Bou","year":"2017","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.xcrm.2024.101609_bib35","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","article-title":"beta-Amyloid efflux mediated by p-glycoprotein","volume":"76","author":"Lam","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xcrm.2024.101609_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","article-title":"Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans","volume":"12","author":"Vogelgesang","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.xcrm.2024.101609_bib37","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101609_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2045-8118-10-13","article-title":"Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in\u00a0vivo optical imaging","volume":"10","author":"Zhang","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.xcrm.2024.101609_bib39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101609_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neures.2006.07.006","article-title":"Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier","volume":"56","author":"Ito","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.258","article-title":"A\u03b21-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-\u03baB\u00a0signaling","volume":"5","author":"Park","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2024.101609_bib42","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1007\/s11095-013-1116-2","article-title":"Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease","volume":"30","author":"Mehta","year":"2013","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.xcrm.2024.101609_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neuropharm.2017.08.002","article-title":"Intact blood-brain barrier transport of small molecular drugs in animal models of amyloid beta and alpha-synuclein pathology","volume":"128","author":"Gustafsson","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xcrm.2024.101609_bib44","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1177\/0271678X16660984","article-title":"An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter","volume":"37","author":"Kannan","year":"2017","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.xcrm.2024.101609_bib45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0271678X18806640","article-title":"Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET","volume":"40","author":"Zoufal","year":"2020","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.xcrm.2024.101609_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/brain\/awr298","article-title":"Blood-brain barrier P-glycoprotein function in Alzheimer's disease","volume":"135","author":"van Assema","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2024.101609_bib47","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2967\/jnumed.113.130161","article-title":"Activity of P-Glycoprotein, a beta-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease","volume":"55","author":"Deo","year":"2014","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.xcrm.2024.101609_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00186","article-title":"Preventing P-gp Ubiquitination Lowers A\u03b2 Brain Levels in an Alzheimer\u2019s Disease Mouse Model","volume":"10","author":"Hartz","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.xcrm.2024.101609_bib49","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/jcbfm.2009.42","article-title":"P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta","volume":"29","author":"Tai","year":"2009","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.xcrm.2024.101609_bib50","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI57867","article-title":"Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice","volume":"121","author":"Krohn","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101609_bib51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1471-4159.2012.07783.x","article-title":"Abcg2 deficiency augments oxidative stress and cognitive deficits in Tg-SwDI transgenic mice","volume":"122","author":"Zeng","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xcrm.2024.101609_bib52","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1471-4159.2010.06887.x","article-title":"ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease","volume":"114","author":"Shen","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xcrm.2024.101609_bib53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","article-title":"ABC efflux transporters in brain vasculature of Alzheimer's subjects","volume":"1358","author":"Wijesuriya","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.xcrm.2024.101609_bib55","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","article-title":"Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology","volume":"45","author":"Abbott","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.xcrm.2024.101609_bib56","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1240514","article-title":"Neuroscience. Garbage truck of the brain","volume":"340","author":"Nedergaard","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101609_bib57","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00401-018-1812-4","article-title":"The role of brain barriers in fluid movement in the CNS: is there a 'glymphatic' system?","volume":"135","author":"Abbott","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2024.101609_bib58","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/glia.22886","article-title":"Dual pathways mediate beta-amyloid stimulated glutathione release from astrocytes","volume":"63","author":"Ye","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.xcrm.2024.101609_bib59","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2024.101609_bib60","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","article-title":"Amyotrophic Lateral Sclerosis: An Update for 2018","volume":"93","author":"Oskarsson","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.xcrm.2024.101609_bib61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.expneurol.2008.06.010","article-title":"Nordihydroguaiaretic acid increases glutamate uptake in\u00a0vitro and in\u00a0vivo: therapeutic implications for amyotrophic lateral sclerosis","volume":"213","author":"Boston-Howes","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib62","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2010.01.078","article-title":"P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis","volume":"472","author":"Milane","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.xcrm.2024.101609_bib63","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2012.03.040","article-title":"Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS","volume":"47","author":"Jablonski","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xcrm.2024.101609_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2016.12.049","article-title":"Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model","volume":"639","author":"Chan","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.xcrm.2024.101609_bib65","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/glia.23003","article-title":"Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis","volume":"64","author":"Qosa","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.xcrm.2024.101609_bib66","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jaut.2009.10.006","article-title":"T lymphocytes impair P-glycoprotein function during neuroinflammation","volume":"34","author":"Kooij","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.xcrm.2024.101609_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.expneurol.2019.04.002","article-title":"Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis","volume":"316","author":"Mohamed","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.08.060","article-title":"ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis","volume":"1607","author":"Jablonski","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib69","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/acn3.141","article-title":"Inhibiting drug efflux transporters improves efficacy of ALS therapeutics","volume":"1","author":"Jablonski","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2014.10.009","article-title":"Genetic causes of amyotrophic lateral sclerosis: New genetic analysis methodologies entailing new opportunities and challenges","volume":"1607","author":"Marangi","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib71","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnen\/nlz142","article-title":"Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients","volume":"79","author":"van Vliet","year":"2020","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2024.101609_bib73","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101609_bib74","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","article-title":"Exposure to pesticides or solvents and risk of Parkinson disease","volume":"80","author":"Pezzoli","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2024.101609_bib75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/jpet.115.226373","article-title":"P-Glycoprotein Transport of Neurotoxic Pesticides","volume":"355","author":"Lacher","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.xcrm.2024.101609_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00441-008-0686-5","article-title":"Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients","volume":"334","author":"Westerlund","year":"2008","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib77","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood-brain barrier dysfunction in parkinsonian midbrain in\u00a0vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib78","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","article-title":"Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA","volume":"115","author":"Bartels","year":"2008","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.xcrm.2024.101609_bib79","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.11.007","article-title":"Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease","volume":"14","author":"Bartels","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.xcrm.2024.101609_bib80","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2741\/4206","article-title":"Disruption of the blood-brain barrier in Parkinson's disease: curse or route to a cure?","volume":"19","author":"Lee","year":"2014","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.xcrm.2024.101609_bib81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.18433\/J3B596","article-title":"Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration","volume":"12","author":"Vautier","year":"2009","journal-title":"J.\u00a0Pharm. Pharm. Sci."},{"key":"10.1016\/j.xcrm.2024.101609_bib82","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acn3.167","article-title":"ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout","volume":"2","author":"Matsuo","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib83","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple Sclerosis: Mechanisms and Immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.xcrm.2024.101609_bib84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/jnnp-2017-316011","article-title":"Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier","volume":"89","author":"Spencer","year":"2018","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.xcrm.2024.101609_bib85","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/brain\/awt324","article-title":"Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis","volume":"137","author":"Al-Izki","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2024.101609_bib86","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/brain\/awq330","article-title":"Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis","volume":"134","author":"Kooij","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2024.101609_bib87","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/brain\/awh707","article-title":"Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis","volume":"129","author":"Boven","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2024.101609_bib88","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-014-1244-8","article-title":"P-glycoprotein regulates trafficking of CD8(+) T\u00a0cells to the brain parenchyma","volume":"127","author":"Kooij","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2024.101609_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008212","article-title":"P-glycoprotein acts as an immunomodulator during neuroinflammation","volume":"4","author":"Kooij","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101609_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893702","article-title":"Improving Glucocorticoid Sensitivity of Brain-Homing CD4(+) T Helper Cells by Steroid Hormone Crosstalk","volume":"13","author":"Koetzier","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101609_bib91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The Epidemiology of Epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.xcrm.2024.101609_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2024.101609_bib93","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101609_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1995.tb01657.x","article-title":"MDR1 gene expression in brain of patients with medically intractable epilepsy","volume":"36","author":"Tishler","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.xcrm.2024.101609_bib95","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","article-title":"Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy","volume":"42","author":"Dombrowski","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.xcrm.2024.101609_bib96","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/brain\/awf002","article-title":"Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy","volume":"125","author":"Sisodiya","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2024.101609_bib97","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0306-4522(02)00992-2","article-title":"Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors","volume":"118","author":"Aronica","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.xcrm.2024.101609_bib98","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2003.10.012","article-title":"Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures","volume":"123","author":"Volk","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.xcrm.2024.101609_bib99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.eplepsyres.2004.06.005","article-title":"Selective and persistent upregulation of mdr1b mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats","volume":"60","author":"van Vliet","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","article-title":"The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy","volume":"24","author":"Brandt","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xcrm.2024.101609_bib101","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1474-4422(13)70109-1","article-title":"P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study","volume":"12","author":"Feldmann","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib102","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/WNL.0000000000000858","article-title":"In\u00a0vivo P-glycoprotein function before and after epilepsy surgery","volume":"83","author":"Bauer","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2024.101609_bib103","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1528-1167.2010.02678.x","article-title":"Induction of sodium channel Na(x) (SCN7A) expression in rat and human hippocampus in temporal lobe epilepsy","volume":"51","author":"Gorter","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.xcrm.2024.101609_bib104","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.0013-9580.2004.57703.x","article-title":"Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy","volume":"45","author":"Aronica","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.xcrm.2024.101609_bib105","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2005.00250.x","article-title":"Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats","volume":"46","author":"van Vliet","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.xcrm.2024.101609_bib106","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eplepsyres.2005.11.011","article-title":"Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis","volume":"68","author":"Kubota","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib107","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1528-1167.2005.66604.x","article-title":"Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain","volume":"46","author":"Aronica","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.xcrm.2024.101609_bib108","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2017.02.014","article-title":"Upregulation of breast cancer resistance protein and major vault protein in drug resistant epilepsy","volume":"47","author":"Banerjee Dixit","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.xcrm.2024.101609_bib109","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.neuropharm.2010.01.007","article-title":"Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in\u00a0pharmacoresistant epilepsy","volume":"58","author":"Luna-Tort\u00f3s","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xcrm.2024.101609_bib110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2013.03.049","article-title":"Impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models","volume":"710","author":"Nakanishi","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101609_bib111","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"Loscher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.xcrm.2024.101609_bib112","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.107.041210","article-title":"Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling","volume":"73","author":"Bauer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101609_bib113","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1474-4422(22)00213-7","article-title":"Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy","volume":"21","author":"Curatolo","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib114","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0887-8994(99)00074-0","article-title":"Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy","volume":"21","author":"Lazarowski","year":"1999","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0887-8994(03)00407-7","article-title":"Multidrug resistance proteins in\u00a0tuberous sclerosis and refractory epilepsy","volume":"30","author":"Lazarowski","year":"2004","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib116","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1789.2008.00920.x","article-title":"Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex","volume":"28","author":"Boer","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.xcrm.2024.101609_bib117","first-page":"20","article-title":"New proteins configure a brain drug resistance map in tuberous sclerosis","volume":"34","author":"Lazarowski","year":"2006","journal-title":"Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib118","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1158\/1078-0432.CCR-16-1276","article-title":"PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models","volume":"23","author":"Lin","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib119","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/noab269","article-title":"Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma","volume":"24","author":"Yabo","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101609_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood-brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Resist. Updat."},{"key":"10.1016\/j.xcrm.2024.101609_bib121","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF00293387","article-title":"The multidrug-resistance gene MDR1 is expressed in human glial tumors","volume":"82","author":"Becker","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2024.101609_bib122","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3171\/jns.1991.75.6.0941","article-title":"Multidrug resistance gene (MDR1) expression in human brain tumors","volume":"75","author":"Nabors","year":"1991","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.xcrm.2024.101609_bib123","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1440-1789.2008.00983.x","article-title":"Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas","volume":"29","author":"Nakagawa","year":"2009","journal-title":"Neuropathology"},{"key":"10.1016\/j.xcrm.2024.101609_bib124","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00230349","article-title":"Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas","volume":"425","author":"Tanaka","year":"1994","journal-title":"Virchows Arch."},{"key":"10.1016\/j.xcrm.2024.101609_bib125","first-page":"853","article-title":"MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors","volume":"149","author":"Toth","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2024.101609_bib126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02478898","article-title":"Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumors","volume":"16","author":"Sawada","year":"1999","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.xcrm.2024.101609_bib127","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1750-3639.2010.00389.x","article-title":"P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) localize in the microvessels forming the blood-tumor barrier in ependymomas","volume":"20","author":"Ginguene","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.xcrm.2024.101609_bib128","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1096\/fj.02-1131fje","article-title":"The expression and functional characterization of ABCG2 in brain endothelial cells and vessels","volume":"17","author":"Zhang","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.xcrm.2024.101609_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061512","article-title":"In\u00a0vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma","volume":"8","author":"Veringa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101609_bib130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","article-title":"PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells","volume":"4","author":"Bleau","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2024.101609_bib131","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1158\/1078-0432.CCR-14-0084","article-title":"ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy","volume":"20","author":"Lin","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib132","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00432-009-0578-4","article-title":"ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma","volume":"135","author":"Jin","year":"2009","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101609_bib133","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11060-017-2422-z","article-title":"Expression and function of ABCG2 and XIAP in glioblastomas","volume":"133","author":"Emery","year":"2017","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101609_bib134","article-title":"ATP-binding cassette transporters restrict drug delivery and efficacy against brain tumors even when blood-brain barrier integrity is lost","volume":"2","author":"de Gooijer","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2024.101609_bib135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-004-6152-7","article-title":"Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma","volume":"74","author":"Calatozzolo","year":"2005","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101609_bib136","doi-asserted-by":"crossref","first-page":"11419","DOI":"10.1158\/0008-5472.CAN-05-1271","article-title":"ABCC Drug Efflux Pumps and Organic Anion Uptake Transporters in Human Gliomas and the Blood-Tumor Barrier","volume":"65","author":"Bronger","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib137","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/B:NEON.0000013484.73208.a4","article-title":"Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1","volume":"66","author":"Benyahia","year":"2004","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101609_bib138","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/07357900801975264","article-title":"Differences in the expression pattern of P-glycoprotein and MRP1 in low-grade and high-grade gliomas","volume":"26","author":"de Faria","year":"2008","journal-title":"Cancer Invest."},{"key":"10.1016\/j.xcrm.2024.101609_bib139","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.celrep.2019.09.088","article-title":"A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes","volume":"29","author":"Dusart","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101609_bib140","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/neuonc\/noab022","article-title":"Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profiling","volume":"23","author":"Schaffenrath","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101609_bib141","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13550-019-0581-y","article-title":"Assessment of brain delivery of a model ABCB1\/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography","volume":"9","author":"Wulkersdorfer","year":"2019","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib142","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11060-018-2917-2","article-title":"Rethinking medulloblastoma from a targeted therapeutics perspective","volume":"139","author":"Hashimoto","year":"2018","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101609_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-007-9382-7","article-title":"Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system. 85","volume":"85","author":"Valera","year":"2007","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.xcrm.2024.101609_bib144","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/2051-5960-2-57","article-title":"Overcoming multiple drug resistance mechanisms in medulloblastoma","volume":"2","author":"Othman","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.xcrm.2024.101609_bib145","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1158\/0008-5472.CAN-15-0030","article-title":"ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to Chemotherapy","volume":"75","author":"Morfouace","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib146","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.4238\/2015.April.13.15","article-title":"Isolation and characterization of cancer stem cells from medulloblastoma","volume":"14","author":"Liu","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib147","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ijc.1306","article-title":"Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors","volume":"93","author":"Demeule","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101609_bib148","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cncr.24735","article-title":"Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2\/neu-positive breast cancer","volume":"116","author":"Yonemori","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2024.101609_bib149","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/cts.12978","article-title":"Quantitative protein expression of blood-brain barrier transporters in the vasculature of brain metastases of patients with lung and breast cancer","volume":"14","author":"Bao","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.xcrm.2024.101609_bib150","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1158\/1078-0432.CCR-16-1327","article-title":"Impact of Blood\u2013Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases","volume":"22","author":"Osswald","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101609_bib151","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Johnson","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib152","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.2174\/138161211797440195","article-title":"ATP-binding cassette transporters at the blood-brain barrier in ischaemic stroke","volume":"17","author":"Patak","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.xcrm.2024.101609_bib153","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.0022-3042.2001.00660.x","article-title":"P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress","volume":"80","author":"Felix","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xcrm.2024.101609_bib154","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1471-4159.2009.06306.x","article-title":"P-glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia-reoxygenation","volume":"111","author":"Robertson","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.xcrm.2024.101609_bib155","article-title":"Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats","volume":"11","author":"DeMars","year":"2017","journal-title":"J.\u00a0Exp. Neurosci."},{"key":"10.1016\/j.xcrm.2024.101609_bib156","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fncel.2014.00352","article-title":"The pivotal role of astrocytes in an in\u00a0vitro stroke model of the blood-brain barrier","volume":"8","author":"Neuhaus","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.xcrm.2024.101609_bib157","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neuroscience.2006.07.056","article-title":"Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats","volume":"142","author":"Dazert","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.xcrm.2024.101609_bib158","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nn1676","article-title":"Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia","volume":"9","author":"Spudich","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2024.101609_bib159","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jphp.12033","article-title":"Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats","volume":"65","author":"Cen","year":"2013","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101609_bib160","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/STROKEAHA.110.608547","article-title":"Natural vitamin E alpha-tocotrienol protects against ischemic stroke by induction of multidrug resistance-associated protein 1","volume":"42","author":"Park","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.xcrm.2024.101609_bib161","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semcdb.2017.10.016","article-title":"Gene-environment interaction and psychiatric disorders: Review and future directions","volume":"77","author":"Assary","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2024.101609_bib162","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ijnp\/pyy052","article-title":"The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review","volume":"22","author":"Demyttenaere","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.xcrm.2024.101609_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00402","article-title":"Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates","volume":"10","author":"Vita","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101609_bib164","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2007.11.017","article-title":"Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression","volume":"57","author":"Uhr","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.xcrm.2024.101609_bib165","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra2119323","article-title":"Laboratory Diagnosis of Creutzfeldt-Jakob Disease","volume":"386","author":"Zerr","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101609_bib166","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00401-006-0042-3","article-title":"Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease","volume":"111","author":"Vogelgesang","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2024.101609_bib167","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/86486","article-title":"Therapeutic opportunities in polyglutamine disease","volume":"7","author":"Hughes","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101609_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2024.101609_bib169","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood\u2013brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2024.101609_bib170","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.84","article-title":"Traumatic brain injuries","volume":"2","author":"Blennow","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2024.101609_bib171","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/jcbfm.2012.154","article-title":"Early brain injury alters the blood-brain barrier phenotype in parallel with \u03b2-amyloid and cognitive changes in adulthood","volume":"33","author":"Pop","year":"2013","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.xcrm.2024.101609_bib172","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/neu.2015.3879","article-title":"Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans","volume":"33","author":"Willyerd","year":"2016","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.xcrm.2024.101609_bib173","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/neur.2020.0034","article-title":"P-glycoprotein Expression Is Upregulated in a Pre-Clinical Model of Traumatic Brain Injury","volume":"1","author":"Vita","year":"2020","journal-title":"Neurotrauma Rep."},{"key":"10.1016\/j.xcrm.2024.101609_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/S0959-8049(22)01073-5","article-title":"The ABCB1\/ABCG2 inhibitor elacridar is a more potent pharmacoenhancer compared to tariquidar for treatment of intracranial tumors with small molecule drugs","volume":"174","author":"Van Tellingen","year":"2022","journal-title":"Eur. J. Cancer"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124003136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124003136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T12:38:42Z","timestamp":1718973522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124003136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":174,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2666379124003136"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101609","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of ATP-binding cassette transporters in the diseased brain: Context matters","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101609"}}